OB/GYN 1610 - OB/GYN Clinical Alert - Oct 01, 2012

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Jeffrey T. Jensen, MD, MPH
Leon Speroff
Professor and Vice Chair for Research
Department of Obstetrics and Gynecology
Oregon Health and Science University
Portland

Peer Reviewer
Catherine Leclair, MD
Associate Professor
Department of OB/GYN
Oregon Health & Science University
Portland

Executive Editor
Leslie G. Coplin
AHC Media

Managing Editor
Neill L. Kimball
AHC Media

Associate Editors
Robert L. Coleman, MD
Professor
University of Texas
M.D. Anderson Cancer Center
Houston

Rebecca H. Allen, MD, MPH
Assistant Professor
Department of Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Women and Infants Hospital
Providence, RI

John C. Hobbins, MD
Professor of Obstetrics and Gynecology
University of Colorado Anschutz Medical Campus
Aurora, CO

Subjects:

  • The Changing Paradigm of Vulva Cancer Management
  • Testing for Chlamydia and Gonorrhea in Pregnancy
  • Intrauterine Growth Restriction

Objectives:

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women?s health

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Jeffrey T. Jensen, MD, MPH, is a consultant for Agile Pharmaceuticals, Bayer Healthcare, HRA Pharma, and Merck, is a speaker for Bayer Healthcare and Merck; and receives research support from Agile Pharmaceuticals, Abbott Pharmaceuticals, Bayer Healthcare, HRA Pharma, and Medicines-360. Peer Reviewer Catherine LeClair, MD, Executive Editor Leslie G. Coplin, Managing Editor Neill Kimball, Associate Editors Robert L. Coleman, MD, Rebecca H. Allen, MD, MPH, and John C. Hobbins, report no financial relationship to this field of study.

Copyright 2012 AHC Media. All rights reserved.